Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at SITC 2026
The company says the Phase 2 AMPLIFY-7P results will be presented in a keynote/plenary session and late-breaking poster at the SITC 2026 Annual Meeting.
The company says the Phase 2 AMPLIFY-7P results will be presented in a keynote/plenary session and late-breaking poster at the SITC 2026 Annual Meeting.